Human Fibrinogen (FBG) ELISA Kit

$407.00

Catalog Number: EF1040-2

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Additional information

Format

Competitive ELISA

Entrez Gene

2243, 2244, 2266

Components

Biotinylated Human Fibrinogen Protein, Chromogen Substrate (1x), Human Fibrinogen Microplate, Human Fibrinogen Standard, MIX Diluent Concentrate (10x), Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

2 hours

Sensitivity

2.9 µg/ml

Range

5 – 80 ug/ml

Samples Type

Plasma

Associated Disease

Blood Disorder, Cardiac

Species

Human

UniProt

P02671, P02675, P02679

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications citing Assaypro: Human Fibrinogen (FBG) ELISA Kit... (47 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

Association of nuts and whole grains intake, inflammation and the metabolic syndrome

Evaluating the effect of antidiabetic treatment on haemostatic and fibrinolytic parameters among type 2 diabetics in Ilorin, Nigeria

Th1-CD11c+ B Cell Axis Associated with Response to Plasmapheresis in Multiple Sclerosis

Association of Serum Fibrinogen and Plasma VEGF Levels with Tumor Characteristics and Treatment Response in Operable Breast Carcinoma.

In vitro blood compatibility evaluation method: incubating while rotating hemodialyzers filled with fresh human blood

Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute on chronic liver failure: An observational cohort study

Multi-targeted therapy of hepatic fibrosis by adipose tissue derived mesenchymal stem cells

Pleural effusion and plasma levels of fibrinolytic parameters in tuberculosis pleurisy and contribution to the diagnosis

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease

Assessment of some plasma fibrinolytic proteins in sickle cell anemia patients in steady state and in vaso-occlusive crises

Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model

Concentrated Plasma as a Carrier for Stem Cell Delivery

Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue

Technique for the control of spheroid diameter using microfabricated chips

Acute Traumatic Coagulopathy: Initiated by Hypoperfusion: Modulated Through the Protein C Pathway?

Autologous fibrinogen purification and concentration for use in fibrin sealant

Th1 - CD11c + B Cell Axis Associated with Response to Plasmapheresis in Multiple Sclerosis.

Acquired hypofibrinogenemia in a patient with multiple myeloma.

Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis.

Analysis of the levels of inflammatory parameters in persons over the age of 90

Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B

The Effectiveness of 3 Combined Therapeutic Regimens in Egyptian Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Randomized Double-Blind Prospective Pilot Study

In vitro blood compatibility evaluation method: incubating while rotating hemodialyzers filled with fresh human blood

Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study.

Analysis of the safety and pharmacodynamics of human fibrinogen concentrate in animals

Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients

Effects of Pristane Alone or Combined with Chloroquine on Macrophage Activation, Oxidative Stress, and Th1/Th2 Skewness

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease

Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells

Haemostatic effects of simvastatin in subjects with impaired glucose tolerance

Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects

Androidal Fat Dominates in Predicting Cardiometabolic Risk in Postmenopausal Women

Plasma Clusterin Levels in Predicting the Occurrence of Coronary Artery Lesions in Patients With Kawasaki Disease

Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus.

Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model

An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease

Trauma-hemorrhagic shock-induced red blood cell damage leads to decreased microcirculatory blood flow*

A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease.

Centrally located body fat is related to inflammatory markers in healthy postmenopausal women

In Vivo Efficacy of a New Autologous Fibrin Sealant

Early Coagulopathy After Traumatic Brain Injury: The Role of Hypoperfusion and the Protein C Pathway

Technique for the control of spheroid diameter using microfabricated chips

Acute Traumatic Coagulopathy: Initiated by Hypoperfusion

New method to prepare autologous fibrin glue on demand

Differentiation Effects by the Combination of Spheroid Formation and Sodium Butyrate Treatment in Human Hepatoblastoma Cell Line (Hep G2): A Possible Cell Source for Hybrid Artificial Liver

Efficacy of a Polyurethane Foam/Spheroid Artificial Liver by Using Human Hepatoblastoma Cell Line (Hep G2)

Loading data...